# US 2019/0290788 A1 · Methods and apparatus for synthesizing imaging agents, and intermediates thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2019/0290788 A1
- Document ID: US20190290788A1
- Status: Published application
- Kind: A1
- Application number: 15/901,286
- Filed: 2018-02-21
- Published: 2019-09-26
- Earliest claimed: 2010-02-08
- Assignees: Lantheus Medical Imaging, Inc.
- Applicants: Lantheus Medical Imaging, Inc.
- Inventors: James F. Castner; Enrico Mongeau; Dianne D. Zdankiewicz; Robert W. Siegler; Richard R. Casati
- Web page: https://patentgrep.com/patent/US20190290788A1

## CPC

- A61K 51/0459: {having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine}
- C07D 237/16: Two oxygen atoms
- C07D 407/12: linked by a chain containing hetero atoms as chain links
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)

## Abstract

The present invention generally relates to methods and system for the synthesis of imaging agents, and precursors thereof. The methods may exhibit improved yields and may allow for the large-scale synthesis of imaging agents, including imaging agents comprising a radioisotope (e.g., 18F). Various embodiments of the invention may be useful as sensors, diagnostic tools, and the like. In some cases, methods for evaluating perfusion, including myocardial perfusion, are provided. Synthetic methods of the invention have also been incorporated into an automated synthesis unit to prepare and purify imaging agents that comprise a radioisotope. In some embodiments, the present invention provides a novel methods and systems comprising imaging agent 1, including methods of imaging in a subject comprising administering a composition comprising imaging agent 1 to a subject by injection, infusion, or any other known method, and imaging the area of the subject wherein the event of interest is located.

## Claims

### Claim at position 1

1-140. (canceled)

### Claim 141

A syringe comprising a composition comprising the imaging agent comprising the formula:
wherein the syringe adsorbs less than 20%, 19%, 18%, 17%, 16%, 15%, 14%, 13% 12%, 11%, 10%, 9%, 8%, 7%, 6%, 5%, 4%, 3%, 2%, 1%, or 0.5% of the imaging agent.

### Claim 142 (depends on 141)

The syringe of claim 141, wherein the syringe comprises a plunger that adsorbs less than 20%, 19%, 18%, 17%, 16%, 15%, 14%, 13% 12%, 11%, 10%, 9%, 8%, 7%, 6%, 5%, 4%, 3%, 2%, 1%, or 0.5% of the imaging agent.

### Claim 143 (depends on 141)

The syringe of claim 141, wherein the syringe comprises a plunger that is not rubber-tipped.

### Claim 144 (depends on 141)

The syringe of claim 141, wherein the syringe further comprises sodium ascorbate, ethanol, and water.

### Claim 145 (depends on 142)

The syringe of claim 142, wherein the imaging agent is in a solution comprising less than 4% ethanol and less than 50 mg/mL sodium ascorbate in water.

### Claim 146 (depends on 141)

The syringe of claim 141, wherein the imaging agent in the syringe is between about 1.5 and about 14 mCi.

### Claim 147 (depends on 141)

The syringe of claim 141, wherein the syringe comprises no rubber, and no silicon lubricants.

### Claim 148 (depends on 141)

The syringe of claim 141, wherein the syringe is a non-reactive syringe.

### Claim 149 (depends on 142)

The syringe of claim 142, wherein the syringe adsorbs between about 1% and about 20%, or between about 5% and about 15%, or between about 1% and about 15%, or between 2% and about 10%, or between about 5% and about 20%.

### Claim at position 11

150-154. (canceled)

### Claim 155

A cassette for the preparation of an imaging agent comprising the formula:
comprising: (i) a vessel containing an imaging agent precursor comprising the formula:
and (ii) a conduit for adding a source of 18F.

### Claim 156 (depends on 155)

An automated reaction system, comprising:
the cassette of claim 155.

### Claim 157

An apparatus for synthesizing an imaging agent comprising a linear arrangement of a plurality of stopcock manifolds connected to one or more of the components selected from the group consisting of a [18O]H2O recovery system, gas inlet, reservoir with solution of imaging agent precursor, vial, anion exchange cartridge, C-18 cartridge, syringe, solvent reservoir, reaction vessel, HPLC system, collection vessel, reservoir for solution of ascorbic acid or salt thereof, and exhaust outlet.

### Claim 158 (depends on 157)

The apparatus of claim 157, further comprising tubing.

### Claim 159 (depends on 158)

The apparatus of claim 158, further comprising an imaging agent synthesis module, wherein the apparatus is fluidically connected to the apparatus.

### Claim 160 (depends on 74, 159)

The apparatus of claim 159, wherein the apparatus is capable of carrying out the method of claim 74.

### Claim 161 (depends on 157)

The apparatus of claim 157, wherein the apparatus is capable of preparing an imaging agent comprising the formula:

### Claim 162 (depends on 157)

The apparatus of claim 157, with the components arranged as shown in FIG. 8.

### Claim 163 (depends on 157)

The apparatus of claim 157, comprising components arranged in the order: (1) gas inlet; (2) [18O]H2O recovery system; (3) anion exchange cartridge; (4) MeCN reservoir; (5) syringe; (6) reservoir with solution of imaging agent precursor; (7) reaction vessel; (8) HPLC system; (9) reservoir with solution of ascorbic acid or a salt thereof; (10) collection vessel; (11) ethanol reservoir; (12) vial with final product; (13) Sep-pack cartridge; (14) reservoir with solution of ascorbic acid or a salt thereof; (15) reaction vessel; and (16) exhaust outlet.
